Beta interferon inhibits HIV-1 Tat-induced angiogenesis: Synergism with 13-cis retinoic acid

M. Iurlaro, R. Benelli, L. Masiello, M. Rosso, L. Santi, A. Albini

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Kaposi's sarcoma (KS) is a highly angiogenic lesion which frequently presents as an aggressive form in HIV-infected male patients. We have previously shown that the HIV-1 Tat protein induces endothelial cell migration and invasion in vitro and a rapid angiogenic response in vivo, suggesting that it acts as a cofactor in epidemic KS. In this study we tested beta interferon (IFNβ) and retinoic acid (RA) for the inhibition of Tat- induced angiogenesis using in vivo and in vitro models. IFNβ, at a concentration above 2500 U/ml, was an effective inhibitor of Tat-stimulated growth, migration and morphogenesis of an endothelial cell line in vitro and of angiogenesis in vivo. A strong reduction of properties associated with neovascularisation was induced by 10 000 U/ml. In vivo, RA alone was on ineffective inhibitor of angiogenesis, and in vitro gave only a limited inhibition of endothelial cell growth. However, 13-cis RA used in combination with IFNβ impressively potentiated its effects. A combination of lower doses of IFNβ (2500 U/ml) and 13-cis RA induced a virtually complete inhibition of the Tat-related angiogenic phenotype both in vivo and in vitro. The potentiation of the anti-angiogenic activity of IFNβ by 13-cis RA suggests that this combination could be a useful approach for the therapy of epidemic KS.

Original languageEnglish
Pages (from-to)570-576
Number of pages7
JournalEuropean Journal of Cancer
Volume34
Issue number4
DOIs
Publication statusPublished - Mar 1998

Fingerprint

Isotretinoin
Interferon-beta
HIV-1
Interferons
Kaposi's Sarcoma
Endothelial Cells
Tretinoin
Human Immunodeficiency Virus tat Gene Products
Angiogenesis Inhibitors
Growth
Morphogenesis
Cell Movement
In Vitro Techniques
HIV
Phenotype
Cell Line

Keywords

  • Angiogenesis
  • HIV-1
  • Interferon
  • Retinoids
  • Tat

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Beta interferon inhibits HIV-1 Tat-induced angiogenesis : Synergism with 13-cis retinoic acid. / Iurlaro, M.; Benelli, R.; Masiello, L.; Rosso, M.; Santi, L.; Albini, A.

In: European Journal of Cancer, Vol. 34, No. 4, 03.1998, p. 570-576.

Research output: Contribution to journalArticle

@article{57ae95d060b747f6bd7a18bdb8d87281,
title = "Beta interferon inhibits HIV-1 Tat-induced angiogenesis: Synergism with 13-cis retinoic acid",
abstract = "Kaposi's sarcoma (KS) is a highly angiogenic lesion which frequently presents as an aggressive form in HIV-infected male patients. We have previously shown that the HIV-1 Tat protein induces endothelial cell migration and invasion in vitro and a rapid angiogenic response in vivo, suggesting that it acts as a cofactor in epidemic KS. In this study we tested beta interferon (IFNβ) and retinoic acid (RA) for the inhibition of Tat- induced angiogenesis using in vivo and in vitro models. IFNβ, at a concentration above 2500 U/ml, was an effective inhibitor of Tat-stimulated growth, migration and morphogenesis of an endothelial cell line in vitro and of angiogenesis in vivo. A strong reduction of properties associated with neovascularisation was induced by 10 000 U/ml. In vivo, RA alone was on ineffective inhibitor of angiogenesis, and in vitro gave only a limited inhibition of endothelial cell growth. However, 13-cis RA used in combination with IFNβ impressively potentiated its effects. A combination of lower doses of IFNβ (2500 U/ml) and 13-cis RA induced a virtually complete inhibition of the Tat-related angiogenic phenotype both in vivo and in vitro. The potentiation of the anti-angiogenic activity of IFNβ by 13-cis RA suggests that this combination could be a useful approach for the therapy of epidemic KS.",
keywords = "Angiogenesis, HIV-1, Interferon, Retinoids, Tat",
author = "M. Iurlaro and R. Benelli and L. Masiello and M. Rosso and L. Santi and A. Albini",
year = "1998",
month = "3",
doi = "10.1016/S0959-8049(97)10082-X",
language = "English",
volume = "34",
pages = "570--576",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "4",

}

TY - JOUR

T1 - Beta interferon inhibits HIV-1 Tat-induced angiogenesis

T2 - Synergism with 13-cis retinoic acid

AU - Iurlaro, M.

AU - Benelli, R.

AU - Masiello, L.

AU - Rosso, M.

AU - Santi, L.

AU - Albini, A.

PY - 1998/3

Y1 - 1998/3

N2 - Kaposi's sarcoma (KS) is a highly angiogenic lesion which frequently presents as an aggressive form in HIV-infected male patients. We have previously shown that the HIV-1 Tat protein induces endothelial cell migration and invasion in vitro and a rapid angiogenic response in vivo, suggesting that it acts as a cofactor in epidemic KS. In this study we tested beta interferon (IFNβ) and retinoic acid (RA) for the inhibition of Tat- induced angiogenesis using in vivo and in vitro models. IFNβ, at a concentration above 2500 U/ml, was an effective inhibitor of Tat-stimulated growth, migration and morphogenesis of an endothelial cell line in vitro and of angiogenesis in vivo. A strong reduction of properties associated with neovascularisation was induced by 10 000 U/ml. In vivo, RA alone was on ineffective inhibitor of angiogenesis, and in vitro gave only a limited inhibition of endothelial cell growth. However, 13-cis RA used in combination with IFNβ impressively potentiated its effects. A combination of lower doses of IFNβ (2500 U/ml) and 13-cis RA induced a virtually complete inhibition of the Tat-related angiogenic phenotype both in vivo and in vitro. The potentiation of the anti-angiogenic activity of IFNβ by 13-cis RA suggests that this combination could be a useful approach for the therapy of epidemic KS.

AB - Kaposi's sarcoma (KS) is a highly angiogenic lesion which frequently presents as an aggressive form in HIV-infected male patients. We have previously shown that the HIV-1 Tat protein induces endothelial cell migration and invasion in vitro and a rapid angiogenic response in vivo, suggesting that it acts as a cofactor in epidemic KS. In this study we tested beta interferon (IFNβ) and retinoic acid (RA) for the inhibition of Tat- induced angiogenesis using in vivo and in vitro models. IFNβ, at a concentration above 2500 U/ml, was an effective inhibitor of Tat-stimulated growth, migration and morphogenesis of an endothelial cell line in vitro and of angiogenesis in vivo. A strong reduction of properties associated with neovascularisation was induced by 10 000 U/ml. In vivo, RA alone was on ineffective inhibitor of angiogenesis, and in vitro gave only a limited inhibition of endothelial cell growth. However, 13-cis RA used in combination with IFNβ impressively potentiated its effects. A combination of lower doses of IFNβ (2500 U/ml) and 13-cis RA induced a virtually complete inhibition of the Tat-related angiogenic phenotype both in vivo and in vitro. The potentiation of the anti-angiogenic activity of IFNβ by 13-cis RA suggests that this combination could be a useful approach for the therapy of epidemic KS.

KW - Angiogenesis

KW - HIV-1

KW - Interferon

KW - Retinoids

KW - Tat

UR - http://www.scopus.com/inward/record.url?scp=0032033453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032033453&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(97)10082-X

DO - 10.1016/S0959-8049(97)10082-X

M3 - Article

C2 - 9713311

AN - SCOPUS:0032033453

VL - 34

SP - 570

EP - 576

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 4

ER -